1-6 of 6
Lluis Lopez-Barcons
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1327: UM-9107: A selective wild-type and T315I Bcr-Abl inhibitor with in vivo activity against chronic myelogenous leukemia

Sameer Phadke, Lluis Lopez-Barcons, Taylor K. Johnson, Eric J. Lachacz, Sofia D. Merajver, Matthew B. Soellner
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1327.
https://doi.org/10.1158/1538-7445.AM2019-1327
Published: 01 July 2019
View article titled, Abstract 1327: UM-9107: A selective wild-type and T315I Bcr-Abl inhibitor with in vivo activity against chronic myelogenous leukemia
Journal Articles

Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM (4-HPR/LXS) oral powder in combination with ketoconazole and vincristine against recurrent neuroblastoma xenografts

Lluis Lopez-Barcons, Min H. Kang, Barry J. Maurer, C. Patrick Reynolds
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2493.
https://doi.org/10.1158/1538-7445.AM2012-2493
Published: 15 April 2012
View article titled, Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORB<sup>TM</sup> (4-HPR/LXS) oral powder in combination with ketoconazole and vincristine against recurrent neuroblastoma xenografts
Journal Articles

Targeting Protein Translation in Human Non–Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression

Marie-Emmanuelle Legrier, Chia-Ping Huang Yang, Han-Guang Yan, Lluis Lopez-Barcons, Steven M. Keller, Roman Pérez-Soler, Susan Band Horwitz, Hayley M. McDaid
Journal: Cancer Research
Cancer Res (2007) 67 (23): 11300–11308.
https://doi.org/10.1158/0008-5472.CAN-07-0702
Published: 03 December 2007
View article titled, Targeting Protein Translation in Human Non–Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression
Open the PDF for Targeting Protein Translation in Human Non–Small Cell Lung Cancer via Combined MEK and Mammalian Target of Rapamycin Suppression in another window
Includes: Supplementary data
Journal Articles

Frequent loss of heterozygosity at 14q13.3 in lung cancer

Dionne Lutz, Jana Sapkar, Lluis Lopez-Barcons, Steven Keller, Roman Perez-Soler, Joseph Locker
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 767.
Published: 15 April 2006
View article titled, Frequent loss of heterozygosity at 14q13.3 in lung cancer
Journal Articles

Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human Heterotransplants

Hayley M. McDaid, Lluis Lopez-Barcons, Aaron Grossman, Marie Lia, Steven Keller, Román Pérez-Soler, Susan Band Horwitz
Journal: Cancer Research
Cancer Res (2005) 65 (7): 2854–2860.
https://doi.org/10.1158/0008-5472.CAN-04-4391
Published: 01 April 2005
View article titled, Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human Heterotransplants
Open the PDF for Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human Heterotransplants in another window
Includes: Supplementary data
Journal Articles

The N- ras Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene

Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, Marcos Malumbres, Ignacio Perez de Castro, Jeffrey Lue, Neus Ferrer-Miralles, Ramon Mangues, Jerry Tsong, Roberto Garcia, Roman Perez-Soler, Angel Pellicer
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4514–4518.
Published: 01 August 2002
View article titled, The N- <em>ras</em> Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene
Open the PDF for The N- <em>ras</em> Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene in another window